Multiple law enforcement agencies closed out the month of January by confiscating an extraordinary amount of illegal drugs in ...

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has ...

In a ground-breaking development, researchers from Emory University and QIMR Berghofer Medical Research Institute in ...

CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.

New research reveals Ozempic users may face twice the risk of developing a rare but irreversible form of vision loss. Danish ...

Fixed-income seniors are bearing the brunt of skyrocketing prescription drug prices, according to a shocking new analysis.

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

II-73, has the potential to restore memory and cognitive function in a mouse model of Alzheimer's disease. The study demonstrates that the drug improves memory deficits and reverses brain cell damage, ...

The results could sway U.S. regulators to convert Braftovi’s accelerated clearance in colorectal tumors into a full approval ...

Brain cancer is the second-leading cause of death in children in the developed world. For the children who survive, standard ...